NDAORALSUSPENSION
Approved
Jun 1996
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
20
Data completeness
5/8 — Partial
CHILDREN'S ADVIL (ibuprofen) by GSK is cyclooxygenase inhibitors [moa]. Approved for pain, fever, postoperative pain and 6 more indications. First approved in 1996.
Drug data last refreshed 20h ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
Children's Advil is an oral ibuprofen suspension, a nonsteroidal anti-inflammatory drug that inhibits cyclooxygenase enzymes to reduce pain and fever. It is indicated for pediatric pain management across multiple conditions including fever, dental pain, postoperative pain, and inflammatory arthritis conditions. The formulation is designed specifically for pediatric dosing and palatability.
LOE Approaching
As an aging, off-patent OTC product in the mature NSAID market with low competitive pressure score (30), this brand faces declining revenue and likely reduced team investment focus.
Mechanism of Action
Cyclooxygenase Inhibitors
Pharmacologic Class:
Nonsteroidal Anti-inflammatory Drug
Indications (9)
Worked on CHILDREN'S ADVIL at GSK? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.